Movement, Involuntary

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Movement, Involuntary trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT00001208

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

BTX has been used since the 1980s in support of the research mission of NINDS. Initial studies were focused on expanding the applicability of BTX treatment to m…

United States2,000 participantsStarted 1989-10-26

All recent trials (27 shown)

Not Yet RecruitingPhase 4

NCT06997198

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

The primary goal of this study is to investigate the efficacy of deutetrabenazine treatment of TD in this previously untreated patient population. Compare movem…

United States25 participantsStarted 2026-05-01

Treatment: Deutetrabenazine Oral Capsule

CompletedPhase 2

NCT06412653

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

The goal of this clinical trial is to investigate feasibility and safety of an oral therapy with zinc in patients affected by Guanine nucleotide-binding protein…

Germany13 participantsStarted 2024-08-02

Treatment: Zinc Acetate Dihydrate

Movement, Involuntary

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

All recent trials (27 shown)

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

All recent trials (27 shown)

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

NETTI Wheelchair: Does Dynamic Mode or Static Mode Affect the Sitting Position in Patients With Involuntary Movements ?

Risperidone for the Treatment of Huntington's Disease Involuntary Movements

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)

Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia

Exercise Training in Dystonia

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

Abnormal Hyperkinetic Movements Post Acute Stroke

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

Addressing Involuntary Movements in Tardive Dyskinesia

Pattern and Frequency of Non-epileptic Involuntary Movements

Hyperkinetic Movements in Patients With Disease of Motor Neurons and Their Response to Treatment With Nusinersen

PET Scan to Study Brain Control of Human Movement

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Assessment of the Effects of Mental Practice on Tongue Strength in Brain-damaged Patients

Mental Practice on Balance